中国医学创新  2024, Vol. 21 Issue (4): 58-62    DOI: 10.3969/j.issn.1674-4985.2024.04.014
Clinical research Current Issue | Archive | Adv Search |
The Effect of Recombinant Human Endostatin on Tumor Factors in Middle and Advanced Stage Non-small Cell Lung Cancer
ZHU Xuzhen
First-author's address: Department of Oncology Ⅲ, Yankuang New Mileage General Hospital, Zoucheng 273500, China
© 2016 中国医学创新 editorial
Address: Beijing south cellular road number five      Postcodes: 100055